FOSB

FBJ murine osteosarcoma viral oncogene homolog B,又名为FOSBFosB,是一个在人体中由FOSB 基因编码(encoded)的蛋白质[参⁠ 1][参⁠ 2][参⁠ 3]FOS 基因家族由四个成员组成:FOS、 FOSB、 FOSL1、和FOSL2。 这些基因组成(encode) 亮氨酸拉链(leucine zipper)蛋白质。这种蛋白质可以与JUN 这个蛋白质及其家族 (e.g., c-JunJunD) 二聚体化(dimerize),然后形成转录因子(transcription factor)综合区-AP-1转录因子[注⁠ 1]

FOSB
识别号
别名FOSB;, AP-1, G0S3, GOS3, GOSB, FosB, ΔFosB, FosB proto-oncogene, AP-1 transcription factor subunit
外部IDOMIM164772 MGI95575 HomoloGene31403 GeneCardsFOSB
基因位置(人类
19号染色体
染色体19号染色体[1]
19号染色体
FOSB的基因位置
FOSB的基因位置
基因座19q13.32起始45,467,995 bp[1]
终止45,475,179 bp[1]
RNA表达模式
查阅更多表达数据
直系同源
物种人类小鼠
Entrez

2354

14282

Ensembl

ENSG00000125740

ENSMUSG00000003545

UniProt

P53539

P13346

mRNA串行

​NM_001114171
​NM_006732

NM_008036
​NM_001347586

蛋白串行

NP_001107643
​NP_006723

NP_001334515
​NP_032062

基因位置(UCSC)Chr 19: 45.47 – 45.48 MbChr 7: 19.04 – 19.04 Mb
PubMed查找[3][4]
维基数据

如同这些,FOS蛋白质就被表示成关于细胞增加、细胞差异化、细胞转型的调节者。 [注⁠ 2][参⁠ 1]

FosB与其选择性剪接形成的产物——“ΔFosB”和进一步剪接而成的“'Δ2ΔFosB”都参与到了骨硬化的过程之中,但 Δ2ΔFosB 没有已知的转录活化区域,无法通过AP-1 复合物影响转录过程。[参⁠ 4]

现已知ΔFosB之端点衔接处变化程度是发展并维持病理行为神经可塑性的内核因素(充分且必要因素)。而病理行为神经可塑性都参与了行为成瘾(与自然酬赏相关)及药物成瘾的形成过程。[参⁠ 5]

注解

[注⁠ 3]
  1. 原文:hese genes encode leucine zipper proteins that can dimerize with proteins of the JUN family (e.g., c-Jun, JunD), thereby forming the transcription factor complex AP-1.
  2. 原文:As such, the FOS proteins have been implicated as regulators of cell proliferation, differentiation, and transformation.

参考数据

[参⁠ 6]
  1. . (原始内容存档于2019-10-16).
  2. Siderovski DP, Blum S, Forsdyke RE, Forsdyke DR. . DNA and Cell Biology. Oct 1990, 9 (8): 579–87. PMID 1702972. doi:10.1089/dna.1990.9.579.
  3. Martin-Gallardo A, McCombie WR, Gocayne JD, FitzGerald MG, Wallace S, Lee BM, Lamerdin J, Trapp S, Kelley JM, Liu LI. . Nature Genetics. Apr 1992, 1 (1): 34–9. PMID 1301997. doi:10.1038/ng0492-34.
  4. Sabatakos G, Rowe GC, Kveiborg M, Wu M, Neff L, Chiusaroli R, Philbrick WM, Baron R. . Journal of Bone and Mineral Research. 2008-05, 23 (5): 584–95. PMC 2674536可免费查阅. PMID 18433296. doi:10.1359/jbmr.080110.
  5. Ruffle JK. . The American Journal of Drug and Alcohol Abuse. Nov 2014, 40 (6): 428–37. PMID 25083822. doi:10.3109/00952990.2014.933840.
    ΔFosB as a therapeutic biomarker
    The strong correlation between chronic drug exposure and ΔFosB provides novel opportunities for targeted therapies in addiction (118), and suggests methods to analyze their efficacy (119). Over the past two decades, research has progressed from identifying ΔFosB induction to investigating its subsequent action (38). It is likely that ΔFosB research will now progress into a new era – the use of ΔFosB as a biomarker. If ΔFosB detection is indicative of chronic drug exposure (and is at least partly responsible for dependence of the substance), then its monitoring for therapeutic efficacy in interventional studies is a suitable biomarker (Figure 2). Examples of therapeutic avenues are discussed herein. ...

    Conclusions
    ΔFosB is an essential transcription factor implicated in the molecular and behavioral pathways of addiction following repeated drug exposure. The formation of ΔFosB in multiple brain regions, and the molecular pathway leading to the formation of AP-1 complexes is well understood. The establishment of a functional purpose for ΔFosB has allowed further determination as to some of the key aspects of its molecular cascades, involving effectors such as GluR2 (87,88), Cdk5 (93) and NFkB (100). Moreover, many of these molecular changes identified are now directly linked to the structural, physiological and behavioral changes observed following chronic drug exposure (60,95,97,102). New frontiers of research investigating the molecular roles of ΔFosB have been opened by epigenetic studies, and recent advances have illustrated the role of ΔFosB acting on DNA and histones, truly as a ‘‘molecular switch’’ (34). As a consequence of our improved understanding of ΔFosB in addiction, it is possible to evaluate the addictive potential of current medications (119), as well as use it as a biomarker for assessing the efficacy of therapeutic interventions (121,122,124). Some of these proposed interventions have limitations (125) or are in their infancy (75). However, it is hoped that some of these preliminary findings may lead to innovative treatments, which are much needed in addiction.


外部链接

相关条目

相关主题:

FOSB引用了美国国家医学图书馆提供的数据,这些数据属于公共领域

  1. GRCh38: Ensembl release 89: ENSG00000125740 - Ensembl, May 2017
  2. GRCm38: Ensembl release 89: ENSMUSG00000003545 - Ensembl, May 2017
  3. . National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. . National Center for Biotechnology Information, U.S. National Library of Medicine.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.